CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-06 | Swanson Ronald V. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2022-09-06 | Patel Piyush R. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2022-09-06 | Patel Piyush R. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +30,924 | 30,924 | ||
| 2022-09-06 | Hudkins Robert L. Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2022-09-06 | Harris Todd Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +270,000 | 270,000 | ||
| 2022-09-06 | Bensen Daniel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2022-09-06 | Bensen Daniel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +249,532 | 249,532 | ||
| 2022-06-13 | Verjee Rehan Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-06-13 | Subramony Siddarth Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-06-13 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-06-13 | Kjellson Nina S Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-06-13 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-06-13 | CHEN ISAN Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-06-13 | Simson Jake Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-06-13 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2022-05-16 | Fawaz Ali D. General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +2,301 | 2,301 | ||
| 2022-05-16 | Fawaz Ali D. General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +3,752 | 3,752 | ||
| 2022-05-16 | Fawaz Ali D. General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +361,586 | 361,586 | ||
| 2022-03-15 | van den Boom Esther Chief Financial Officer | Grant or award | +1,800 | $8.53 | $15K | 120,445 |
| 2022-03-15 | Tada Hiroomi Chief Medical Officer | Grant or award | +2,703 | $8.53 | $23K | 80,625 |
Page 17 of 21 · 417 trades